首页 | 本学科首页   官方微博 | 高级检索  
     


A spectrum of novel NPHS1 and NPHS2 gene mutations in pediatric nephrotic syndrome patients from Pakistan
Authors:Abid Aiysha  Khaliq Shagufta  Shahid Saba  Lanewala Ali  Mubarak Mohammad  Hashmi Seema  Kazi Javed  Masood Tahir  Hafeez Farkhanda  Naqvi Syed Ali Anwar  Rizvi Syed Adeebul Hasan  Mehdi Syed Qasim
Affiliation:Centre for Human Genetics and Molecular Medicine, Sindh Institute of Urology and Transplantation, Karachi, Pakistan.
Abstract:

Background

Mutations in the NPHS1 and NPHS2 genes are among the main causes of early-onset and familial steroid resistant nephrotic syndrome respectively. This study was carried out to assess the frequencies of mutations in these two genes in a cohort of Pakistani pediatric NS patients.

Methods

Mutation analysis was carried out by direct sequencing of the NPHS1 and NPHS2 genes in 145 nephrotic syndrome (NS) patients. This cohort included 36 samples of congenital or infantile onset NS cases and 39 samples of familial cases obtained from 30 families.

Results

A total of 7 homozygous (6 novel) mutations were found in the NPHS1 gene and 4 homozygous mutations in the NPHS2 gene. All mutations in the NPHS1 gene were found in the early onset cases. Of these, one patient has a family history of NS. Homozygous p.R229Q mutation in the NPHS2 gene was found in two children with childhood-onset NS.

Conclusions

Our results show a low prevalence of disease causing mutations in the NPHS1 (22% early onset, 5.5% overall) and NPHS2 (3.3% early onset and 3.4% overall) genes in the Pakistani NS children as compared to the European populations. In contrast to the high frequency of the NPHS2 gene mutations reported for familial SRNS in Europe, no mutation was found in the familial Pakistani cases. To our knowledge, this is the first comprehensive screening of the NPHS1 and NPHS2 gene mutations in sporadic and familial NS cases from South Asia.
Keywords:NS, nephrotic syndrome   SRNS, steroid resistant nephrotic syndrome   CNS, congenital nephrotic syndrome   ESRD, end stage renal disease   MCD, minimal change disease   FSGS, focal segmental glomerulosclerosis   DMS, diffuse mesengial sclerosis   GFB, glomerular filtration barrier   CNF, nephrotic syndrome of Finnish type   eGFR, estimated glomerular filtration rate   DNA, deoxyribonucleic acid   ACD, Acid citrate dextrose   PCR, polymerase chain reaction   MesPGN, mesengial proliferative glomerular nephropathy   MGN, membranous glomerulonephritis   MCGN, mesengio capillary glomerulonephritis   CRF, chronic renal failure   ACEI, angiotensin converting enzyme inhibitor   CyA, cyclosporine   ARB, angiotensin receptor blocker
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号